BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3870629)

  • 1. Intraocular pressure (IOP) changes induced by regular dialysis treatment (RDT).
    Albertazzi A; Di Paolo B; Spisni C; Mastropasqua L; Gallenga PE
    Life Support Syst; 1985; 3 Suppl 1():91-5. PubMed ID: 3870629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in intraocular pressure during dialysis].
    Dujić M; Marković P; Jovanović D; Dragićević P; Radovanović Lj
    Srp Arh Celok Lek; 1997; 125(9-10):257-60. PubMed ID: 9340795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of intraocular pressure elevations during hemodialysis.
    Minguela I; Andonegui J; Aurrekoetxea B; Ruiz De Gauna R
    Am J Kidney Dis; 2000 Jul; 36(1):197-8. PubMed ID: 10873891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraocular pressure during hemodialysis].
    Tawara A
    J UOEH; 2000 Mar; 22(1):33-43. PubMed ID: 10736823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
    Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
    Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of exercise-induced ocular hypotension.
    Martin B; Harris A; Hammel T; Malinovsky V
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):1011-5. PubMed ID: 10102302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
    Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
    Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Chevrier RL; Assalian A; Duperré J; Lesk MR
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of elevation of intraocular pressure over time and associated factors in normal-tension glaucoma.
    Oguri A; Sogano S; Yamamoto T; Kitazawa Y
    J Glaucoma; 1998 Apr; 7(2):117-20. PubMed ID: 9559498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intravitreal triamcinolone on intraocular pressure.
    Kramar M; Vu L; Whitson JT; He YG
    Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in intraocular pressure during hemodialysis in eyes during early postvitrectomy period.
    Yoon YH; Sohn JH; Lee SE; Lee YB; Kim JY; Kook MS
    Ophthalmic Surg Lasers; 2000; 31(6):467-73. PubMed ID: 11095123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pressure during haemodialysis: a review.
    Levy J; Tovbin D; Lifshitz T; Zlotnik M; Tessler Z
    Eye (Lond); 2005 Dec; 19(12):1249-56. PubMed ID: 15543171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide deficit and functional platelet alterations in patients on regular dialysis treatment (RDT).
    Albertazzi A; Spisni C; Palmieri PF; Ruzzi L; Di Guglielmo R; Di Filippo L; Evangelista M
    Life Support Syst; 1985; 3 Suppl 1():77-81. PubMed ID: 3870626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of argon laser treatment of 100 eyes with open-angle glaucoma (trabeculoplasty, trabeculoretraction)].
    Moulin F; Haut J
    J Fr Ophtalmol; 1983; 6(8-9):661-70. PubMed ID: 6687151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular findings in patients with chronic renal failure undergoing haemodialysis.
    Vrabec R; Vatavuk Z; Pavlović D; Sesar A; Cala S; Mandić K; Bućan K
    Coll Antropol; 2005; 29 Suppl 1():95-8. PubMed ID: 16193686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure.
    Lam DS; Leung DY; Tham CC; Li FC; Kwong YY; Chiu TY; Fan DS
    Ophthalmology; 2008 Jul; 115(7):1134-40. PubMed ID: 18164064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transiently raised intraocular pressure reveals pattern electroretinogram losses in ocular hypertension.
    Colotto A; Falsini B; Salgarello T; Buzzonetti L; Cermola S; Porrello G
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2663-70. PubMed ID: 8977480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rise in intraocular pressure during dialysis.
    Dujić M; Jovanović D; Marković P
    Clin Nephrol; 1995 Nov; 44(5):348. PubMed ID: 8605723
    [No Abstract]   [Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.